Grifols
Click HERE to download the PDF version
The world´s major health systems and drug-developing leaders are spending billions to help bring new injectable and infusible therapeutics to the market. The demand for premixed solutions is also therapeutically led. Premixed IV solutions, for example, are the preferred mode of delivery for antibiotics globally and a market segment growing exponentially. Pain management and cardiac medications are most often delivered intravenously, contributing to the ... ... ...
View the issue
You may be interested in:
Recent Posts
- Navigating the Probiotic Landscape: Consumer Insights and Trends
- Vetter strengthens senior management team for further sustainable growth
- Beyond Dairy: Kensing unleashes the Power of Phytosterols for Heart Wellness in New Categories at Fi Europe
- HALLSTAR HAS ACQUIRED SYTHEON, DEVELOPER OF HIGH-PERFORMANCE INGREDIENTS FOR SKIN CARE
- Unlocking the value of sustainability in animal protein value chains with Sustell™
